This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
Three hospital discharge care models were assessed. Two were delivered remotely, over the 60 days after hospital discharge. One was delivered by a two-way video-conference device, with an integrated electronic stethoscope, and the other was nurse telephone calls. These were compared with the usual out-patient care.
Location/setting
USA/primary care.
Methods

Analytical approach:
The cost-effectiveness analysis was based on a clinical study. The time horizon was the follow-up in the study, which was six months. The authors stated that the analysis was conducted from the perspective of the health care system.
Effectiveness data:
A pilot randomised controlled trial was conducted at the University of California Davis Hospital, between July 1999 and June 2000. Patients were assessed using intention-to-treat, with 13 receiving video conferencing, 12 receiving telephone care, and 12 receiving usual care. The primary outcome was the number of readmissions. Secondary outcomes were the Short Form (SF-36) Health Survey score, and the Minnesota Living with Heart Failure Questionnaire (MLHFQ) score. The SF-36 and MLHFQ were completed by all patients, at initial home nurse visit (shortly after discharge), and at a second home nurse visit about 60 days later. Patient satisfaction with care was assessed at both visits, using the eight-item Client Satisfaction Questionnaire (CSQ).
Monetary benefit and utility valuations:
Not applicable.
Measure of benefit:
The main measures of health benefit were the comparative SF-36 and MLHFQ scores. The focus of the analysis was on the benefits measured by readmission cost reductions.
